Recursion Pharmaceuticals snags $2.15 mln

Salt Lake City-based Recursion Pharmaceuticals, a drug discovery company, has raised an additional $2.15 million in funding. The investors in this round included Felicis Ventures.

22 November 2016•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail